Part of
BIOPHARMA
DEVELOPMENT &
PRODUCTION
WEEK

3RD ANNUAL

C LL LINE
DEVELOPMENT &
ENGINEERING ASIA

20 — 23 May 2014
Gr...
Part of
BIOPHARMA
DEVELOPMENT &
PRODUCTION
WEEK

3RD ANNUAL

C LL LINE
20 — 23 May 2014

DEVELOPMENT &
ENGINEERING ASIA

G...
Upcoming SlideShare
Loading in …5
×

Cell Line Development & Engineering Asia 2014

323 views

Published on

The 3rd Cell Line Development & Engineering Asia Conference is taking place on the 20 - 23 May 2014 at Grand Hyatt, Shanghai. A must attend event for you to get the latest updates and best practices in Cell Line Development & Engineering!

A sneak peek at what’s NEW and EXCITING for 2014:

Strategies in using omics to improve the structural quality of specific products
Develop the right cell culture media and feeding strategies
Get unpublished research updates on improving glycosylation and targeted integration
Reduce timelines in your clone selection & screening process
Get new approaches to optimize your transient expression system

Visit http://www.celllineasia.com for more details.

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
323
On SlideShare
0
From Embeds
0
Number of Embeds
1
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Cell Line Development & Engineering Asia 2014

  1. 1. Part of BIOPHARMA DEVELOPMENT & PRODUCTION WEEK 3RD ANNUAL C LL LINE DEVELOPMENT & ENGINEERING ASIA 20 — 23 May 2014 Grand Hyatt Shanghai, China Accelerating Your Cell Line Development with Efficacy & Quality THE 2014 NEW EXPERT FACULTY INCLUDES: Dr Zhao (David) Xiao Jian Senior Vice President & Chief Technology Officer, Wuhan YZY Biopharma, China Dr Chengbin Wu Chief Scientific Officer & President of R&D, Shanghai CP Guojian Pharmaceutical, China Dr H. Fai Poon Director, Cell Culture, Hisun Pharmaceuticals, China What’s New for 2014? Dr Qian Xue Ming CEO & Chairman, Mabspace Biosciences, China New & Unpublished Data on Targeted Integration, Glycosylation, Transient Expression & Clone Selection Cell Line Development Strategies for Complex Biologics Achieve an Ideal Cell Culture Media for High Yield & Reproducibility Navigate the Cell Line Regulatory Landscape for Your Drug Innovative Technology Showcase to Accelerate your Cell Line Development Process Pre-Conference Workshops: 20 May 2014 A Optimizing Cell Culture Media Development & Design Strategies B Cell Banking Management Post-Conference Workshop: 23 May 2014 C The Road to Commercialization: From Cell to Market Co-located with: BI SIMILARS ASIA BIO MANUFACTURING www.celllineasia.com Produced by: Bronze Sponsor: Associate Sponsor: Session Spotlight Sponsors: Exhibitors: Life Sciences Media Partners: Associations: International Marketing Partner: REGISTER NOW! Customer Service Hotline: +65 6508 2401 / +86 21 2326 3680
  2. 2. Part of BIOPHARMA DEVELOPMENT & PRODUCTION WEEK 3RD ANNUAL C LL LINE 20 — 23 May 2014 DEVELOPMENT & ENGINEERING ASIA Grand Hyatt Shanghai, China Accelerating Your Cell Line Development with Efficacy & Quality The global cell culture market is expected to reach USD 16.85 billion globally in 2018 (Transparency Market Research, 2013). However, the development of cell lines is still plagued with many challenges including quality, cost, timelines in the cell line development process, as well as titer. Due to the high cost of biologics production, strategies for cost-effective cell line development solutions to hasten the drug into the market can ultimately lead to high profit margins. About the BDP Week The Biopharma Development & Production Week is the leading industry platform for pharma, biotech, CMOs, CROs, research institutes, investors and industry stakeholders to meet, network and discuss current industry trends, establish business partnerships and be updated on investment opportunities in China and surrounding Asia. Co-Located with: IBC’s Cell Line Development & Engineering Asia brings together top experts and scientists from biopharma, biotechs, research institutes, universities, CMOs and CROs as well as leading technology solutions providers from all over Asia and the rest of the world. It provides a platform where industry and research experts can share research developments, case studies, best practices and discuss challenges pertaining to the cell line development industry to increase the efficacy and quality of cell lines for a faster, safer and more efficient biologics development process. BI ASIA www.biosimilarsasia.com Grow & Benchmark Your Company Profile in the Cell Line Industry BY INDUSTRY: Pharmaceuticals/Biotechnology: 50% Research Institutes/Universities: 10% CMOs: 20% CROs: 10% Technology Providers: 10% BY REGION: ■ ■ ■ ■ ■ ■ BIO MANUFACTURING www.biomanufacturing-asia.com Abundant Networking Opportunities with Regional & Global Companies! Who Should Attend: ■ ■ ■ ■ ■ SIMILARS Build Lasting Partnerships & Networks in a Casual Networking Evening Cocktail China, Taiwan, Hong Kong: 60% Japan, Korea: 10% Rest of Asia: 10% Europe: 10% USA: 5% Australia: 5% Speed Networking with Pharmaceutical & Biotechnology Companies Exchange Business Cards & Get to Know Your Peers in the Shared Morning Ice Breaker Meet VIP Guests at Networking Luncheons Shared Networking Breaks & Exhibition Snapshot of Past Attending Companies Include: Roche Diagnostics • Boehringer-Ingelheim • Genzyme • Sanofi • Shanghai Henlius Biotech • Eureka Therapeutics • Simcere • Luye Pharma • BTI A*Star • Neuclone • Wuhan YZY biopharma • Wuxi apptec • Fountain Biopharma • Novo Nordisk • Harbin Pharmaceutical Group • Genor Biopharma • TTY Biopharm company • JS Biosciences • Hisun Medicine • Genloci Biotechnologies • Shanghai Jiaotong University • University of Queensland • University of Manchester • Swiss Institute of Technology • John Hopkins University School of Medicine • National Health Research Institutes • Autekbio • Genescience • Dragonfly Sciences • Eli Lilly and Company • Hengru Medicine • TPG Biologics • Sinocelltech • Jiangsu Henrui Medicine • Egret Pharma Shanghai • Beijing Mabworks Biotech • Cbiopharm • Japan Asia Inestment (China) • 3SBIO • Jiangsu T-Mab Biopharma • SG Austria • Lonza Biologics • Tap biosystems • Sigma-Alrich • Genscript China • GE Healthcare AND MANY MORE... LIMITED SPONSORSHIP & EXHIBITION OPPORTUNITIES AVAILABLE: Do you provide innovative technology to support cell line development in Asia? • • • • Showcase the latest technology Meet & Network with senior decision makers in Asia Position your brand as the market leader to stand out amidst competition Generate new business contacts and strengthen existing accounts REGISTER TODAY! +65 6508 2401 / +86 21 2326 3680 For sponsorship opportunities, contact Yvonne Leong at Tel: +65 6508 2489 Email: yvonne.leong@ibcasia.com.sg register@ibcasia.com.sg www.celllineasia.com

×